Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Jounce Therapeutics
Biotech
Concentra rebounds with a shot at COVID-19-focused Atea
Weeks after closing a deal to buy Jounce , Concentra is rebounding to pick up another struggling biotech, this time COVID-19-focused Atea Pharma.
Annalee Armstrong
May 22, 2023 11:20am
Jounce jilts Redx for Concentra's surprise merger offer
Mar 27, 2023 10:56am
Biotech makes surprise bid to snatch Jounce out of Redx's hands
Mar 15, 2023 8:48am
Jounce lays off 57% of staff, agrees reverse merger with Redx
Feb 23, 2023 8:00am
Jounce sells remaining stake in antibody to Gilead for $67M
Jan 3, 2023 10:35am
Jounce gets trounced as phase 2 data disappoint once again
Aug 31, 2022 7:30am
